Mineralys Therapeutics, Inc.
MLYS
$25.02
-$0.71-2.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.61% | 82.70% | -5.28% | 73.08% | -24.82% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.97% | -40.42% | -9.82% | 60.25% | 73.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 10.27% | 78.90% | -5.43% | 72.63% | -23.30% |
|
|
|||||
| Total Current Assets | 10.27% | 78.90% | -5.43% | 72.63% | -23.30% |
| Net Property, Plant & Equipment | 442.86% | -68.18% | -42.11% | -28.30% | -23.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 165.28% | -66.74% | 9.07% | -20.44% | 10.40% |
| Total Assets | 10.31% | 78.70% | -5.41% | 72.38% | -23.24% |
|
|
|||||
| Total Accounts Payable | 79.93% | -64.57% | 748.26% | -22.13% | -84.58% |
| Total Accrued Expenses | -41.53% | 17.83% | 46.08% | -8.15% | -49.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -35.74% | 6.07% | 65.64% | -8.60% | -53.24% |
|
|
|||||
| Total Current Liabilities | -35.74% | 6.07% | 65.64% | -8.60% | -53.24% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -35.74% | 6.07% | 65.64% | -8.60% | -53.24% |
|
|
|||||
| Common Stock & APIC | 10.24% | 42.73% | 2.23% | 38.99% | 0.67% |
| Retained Earnings | -7.59% | -9.52% | -12.55% | -13.95% | -19.30% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 12.19% | 83.84% | -8.20% | 78.58% | -19.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.19% | 83.84% | -8.20% | 78.58% | -19.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.19% | 83.84% | -8.20% | 78.58% | -19.28% |
|
|
|||||